Showing 11,241 - 11,260 results of 13,286 for search '"blood"', query time: 0.10s Refine Results
  1. 11241

    Factors associated with hospital length of stay in patients admitted with suspected malaria in Kenya: secondary analysis of a cross-sectional survey by Hillary Kipruto, Beatrice Machini, Jacqueline Chesang, Beatrice Amboko, Thomas N O Achia

    Published 2022-06-01
    “…The cumulative incidence of discharge significantly decreased (p<0.05) by 12.7% (subdistribution-HR (SDHR): 0.873; 95% CI 0.789 to 0.967) when the respiratory rate was assessed, by 14.1% (SDHR 0.859; 95% CI 0.754 to 0.978) when oxygen saturation was monitored, by 23.1% (SDHR 0.769; 95% CI 0.709 to 0.833) and 23.4% (SDHR 0.766; 95% CI 0.704 to 0.833) when haemoglobin/haematocrit and glucose/random blood sugar were performed, respectively, and by 30.4% (SDHR 0.696; 95% CI 0.626 to 0.774) when patients had at least one clinical feature of severe malaria. …”
    Get full text
    Article
  2. 11242

    Readiness to deliver quality curative care for under-five children at health posts in Ethiopia by Dawit Wolde Daka, Muluemebet Abera Wordofa, Mirkuzie Woldie

    Published 2025-01-01
    “…Similarly, availability of essential medical equipment varied from 57% for blood pressure apparatus to 86% for thermometer and 99% for Mid-Upper Arm Circumference tape. …”
    Get full text
    Article
  3. 11243
  4. 11244

    PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial by Mark N. Stein, Ecaterina E. Dumbrava, Benjamin A. Teply, Usama S. Gergis, Martin E. Guiterrez, Ran Reshef, Sumit K. Subudhi, Céline F. Jacquemont, Joseph H. Senesac, J. Henri Bayle, Charity D. Scripture, Monica S. Chatwal, Mehmet A. Bilen, Walter M. Stadler, Carlos R. Becerra

    Published 2024-12-01
    “…BPX-601 cell expansion, long-term persistence in peripheral blood, and tumor infiltration were observed. Rimiducid increased circulating inflammatory cytokines/chemokines consistent with GoCAR-T® cell activation. …”
    Get full text
    Article
  5. 11245

    Salivary cardiac troponin does not correlate with serum levels by Hoa Tran, Vu Hoang Vu, Quang Dang Duy Pham, Duc Minh Tran, Suong Thi Bang Nguyen, Vien Thanh Truong, Binh Quang Truong

    Published 2025-01-01
    “…Patients presenting with chest pain were enrolled, and unstimulated saliva samples were collected using the Navazesh method simultaneously with the initial blood collection. These samples were then analyzed for levels of salivary troponin I, serum troponin I, and serum high-sensitive troponin T.ResultsAmong the 48 patients included, 22 (46%) exhibited myocardial injury, while 12 (25%) were diagnosed with acute myocardial infarction. …”
    Get full text
    Article
  6. 11246

    Impact of Saccharomyces cerevisiae on the intestinal microbiota of dogs with antibiotic-induced dysbiosis by Sara Arghavani, Younes Chorfi, Mariela Segura, Achraf Adib Lesaux, Marcio C. Costa

    Published 2025-02-01
    “…Fecal swabs were collected on D0, 3, 11, 17, 20, 24, and 31 for microbiota analysis and blood on D0 and D24 for measurements of cytokines and cortisol.Results and discussionAt D0, two distinct microbiota profiles comprised of dogs from both groups, control and probiotic, were identified. …”
    Get full text
    Article
  7. 11247

    Towards a decision support system for post bariatric hypoglycaemia: development of forecasting algorithms in unrestricted daily-life conditions by Francesco Prendin, Olivia Streicher, Giacomo Cappon, Eva Rolfes, David Herzig, Lia Bally, Andrea Facchinetti

    Published 2025-01-01
    “…Abstract Background Post bariatric hypoglycaemic (PBH) is a late complication of weight loss surgery, characterised by critically low blood glucose levels following meal-induced glycaemic excursions. …”
    Get full text
    Article
  8. 11248

    Characterization of a New Immunosuppressive and Antimicrobial Peptide, DRS-DA2, Isolated from the Mexican Frog, Pachymedusa dacnicolor by Claire Lacombe, Estefania Aleman-Navaro, Thierry Drujon, Veronica Martinez-Osorio, Emmanuelle Sachon, Erika Melchy-Pérez, Ludovic Carlier, Lorena Elizabeth Fajardo Brigido, Yannick Fleury, Christophe Piesse, Guadalupe Gutiérrez-Escobedo, Alejandro De las Peñas, Irene Castaño, Florie Desriac, Jose Luis Beristain-Hernandez, Christophe Combadiere, Yvonne Rosenstein, Constance Auvynet

    Published 2024-01-01
    “…After the induction of peritonitis, a local injection of DRS-DA2N could decrease the number of inflammatory cells locally in the peritoneal cavity without inducing a systemic effect, as no changes in the number of inflammatory cells could be detected in blood or in the bone marrow. Collectively, these data suggest that this peptide could be a promising tool in the treatment of inflammatory diseases, such as inflammatory skin diseases, as it could reduce the number of inflammatory cells locally without suppressing the ability to combat infections.…”
    Get full text
    Article
  9. 11249

    CCL-2 and CXCL-8: Potential Prognostic Biomarkers of Acute Kidney Injury after a Bothrops atrox Snakebite by Juliana Costa Ferreira Neves, Hiochelson Najibe Santos Ibiapina, Fábio Magalhães-Gama, Jacqueline Almeida Gonçalves Sachett, Iran Mendonça Silva, Kerolaine Fonseca Coelho, Eliane Campos Alves, Andréa Monteiro Tarragô, Luiz Carlos de Lima Ferreira, Adriana Malheiro, Wuelton Marcelo Monteiro, Allyson Guimarães Costa

    Published 2022-01-01
    “…These were categorized into two groups according to the development of AKI (AKI(-)/AKI(+)), using healthy donors as the control (HD). Peripheral blood samples were collected at three-time points: before antivenom administration (T0) and at 24 and 48 hours after antivenom (T1 and T2, respectively). …”
    Get full text
    Article
  10. 11250

    CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent by Anchal Sharma, Anmol Narang, Nitish Kumar, Rupali Rana, Megha, Pooja, Muskan Dhir, Harmandeep Kaur Gulati, Jyoti, Aanchal Khanna, Jatinder Vir Singh, Sukhraj Kaur, Preet Mohinder Singh Bedi

    Published 2025-02-01
    “…In vivo studies demonstrated that Compound I-1 significantly reduced blood glucose levels, with values of 94.15 mg/dL and 74.60 mg/dL at doses of 10 mg/kg and 20 mg/kg, respectively. …”
    Get full text
    Article
  11. 11251

    Changes in Serum Immunoglobulin Levels Play as Predictors of Treatment Response and Prognosis in Pediatric Idiopathic Nephrotic Syndrome During the Remission Phase by Amin sadat Sharif, Naghmeh Nickravesh, Marzieh Heidarzadeh Arani, Mohammad Javad Azadchehr, Hossein Motedayyen

    Published 2025-01-01
    “…Methods The study population consisted of 38 children with INS in the remission phase and 38 age‐ and sex‐matched healthy children. Blood samples were collected from participants and serum values of IgG, IgM, IgE, and IgA were measured using EISA KITS from Aptech Services. …”
    Get full text
    Article
  12. 11252

    Potensi Terapi Fitokanabinoid Mayor dalam Pengobatan Cedera Otak Traumatik: sebuah Tinjauan Literatur Farmakologis by Arief Gunawan Darmanto

    Published 2024-12-01
    “…These major phytocannabinoids are known to influence cannabinoid receptors (CB1 and CB2), which play roles in modulating inflammatory processes, reducing neuronal damage, improving motor and cognitive functions, and regulating recovery mechanisms in the blood-brain barrier and intracranial lymphatics. …”
    Get full text
    Article
  13. 11253

    Antibody and serum bactericidal response to Burkholderia pseudomallei in acute localized and septicemic melioidosis cases with diabetes mellitus by Sraboni Mazumder, Md. Shariful Alam Jilani, Lovely Barai, KM Shahidul Islam

    Published 2025-01-01
    “…Material and methods: Culture positive melioidosis cases with diabetes mellitus were included in the study. Blood samples were collected from the respective cases in active phase of the disease within 1 or 2 days of being culture positive. …”
    Get full text
    Article
  14. 11254

    Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio by Jing Yu, Longzhang Huang, Ting Dong, Lihua Cao

    Published 2024-12-01
    “…NLR (95%CI: 1.256-4.039) and PLR (95%CI:1.281-3.546) were also independent factors affecting DFS.Conclusion NLR and PLR in the peripheral blood before treatment may predict DFS of patients with stage IB2-IIB cervical cancer.…”
    Get full text
    Article
  15. 11255

    Mitigation of doxorubicin-induced liver toxicity in mice breast cancer model by green tea and Moringa oleifera combination: Targeting apoptosis, inflammation, and oxidative stress by Abdulrahman H. Laftah, Nawfal Alhelfi, Sadeq K. Al Salait, Ammar B. Altemimi, Mohammad Reza Tabandeh, Efstathia Tsakali, Jan F.M. Van Impe, Ahmed A. Abd El-Maksoud, Tarek Gamal Abedelmaksoud

    Published 2025-01-01
    “…Histopathological evaluation showed that highly-dose therapy reduced hepatocyte degradation, inflammatory cell infiltration, localized necrosis, and blood vessel congestion. Finally, green tea and Moringa oleifera extracts protect against DOX-induced hepatotoxicity.…”
    Get full text
    Article
  16. 11256

    A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system by Ke He, Kaidi Zhao, Tingyi Yin, Meng Liu, Jiashu Liu, Wenqian Du, Xinyi Liu, Baochen Cheng, Dewu Zhang, Yan Zheng

    Published 2025-01-01
    “…Additionally, we found potential adverse reactions not noted on the drug’s label that exhibited positive signals, including depression, increased blood pressure, peripheral swelling, gait disturbance, inability to walk, stress, myocardial infarction, sepsis, uveitis, nephrolithiasis, and interstitial lung disease. …”
    Get full text
    Article
  17. 11257

    بررسی فاکتورهای بالینی و آزمایشگاهی پیش‌بینی‌کننده‌ی نیاز به دیالیز در شیرخواران و کودکان مبتلا به سندرم اورمیک همولیتیک مراجعه‌کننده به بیمارستان کودکان قزوین در سال‌های 1399 و 14... by غزاله جباری, رضا دلیرانی, بنفشه آراد, نسرین اسفندیار

    Published 2024-06-01
    “…یافته‌ها: در مقایسه‌ی شاخص‌های دموگرافیک، علایم بالینی و آزمایشگاهی در دو گروه کودکان با اندیکاسیون دیالیز و بدون نیاز به دیالیز، در گروه دیالیز میانگین حجم ادرار کمتر، سطح هماتوکریت پایین‌تر، (Blood urea nitrogen) BUN و کراتینین بالاتر و میزان فیلتراسیون گلومرولی (Glomerular filtration rate) GFR کمتر بود (0/05 > P). …”
    Get full text
    Article
  18. 11258

    Bleeding control of an injury to the infrarenal inferior vena cava and right external iliac vein by ipsilateral internal iliac artery and superficial femoral vein ligation after bl... by Hoonsung Park, Maru Kim, Dae-Sang Lee, Tae Hwa Hong, Doo-Hun Kim, Hangjoo Cho

    Published 2023-12-01
    “…We ultimately controlled the bleeding, and approximately 5 L of blood products were infused intraoperatively. A second-look operation was performed 2 days later, by which time most of the bleeding sites had ceased. …”
    Get full text
    Article
  19. 11259

    Can the 3rd Hour Value of 100 g Oral Glucose Tolerance Test Be Ignored in the Diagnosis of Gestational Diabetes Mellitus? by Mehmet Metin Altay, Serdinç Özdoğan, Aytaç Tohma, Sertaç Esin, Okyar Erol, Orhan Gelişen, Melih Akkuş, Sinan Karadeniz

    Published 2013-12-01
    “…CONCLUSION: 79% of the patients were diagnosed with first and second hour test results but 21% of the patients were diagnosed with blood glucose levels above the third hour cut-off level. …”
    Get full text
    Article
  20. 11260

    Independent Heath Facility Meets Cancer Care Ontario and Canadian Association of Gastroenterology Guidelines for Endoscopic Procedure Wait Times While Meeting Quality Indicators: A... by Fraser Kegel, Niv Sne, Timothy Rice, Eric Joy, Shayan Shahsavar, Celeste A. Collins, Maria Gagarine, Alexandra Allard-Coutu, Lisa Klotz, Angela Coates, Kamyar Kahnamoui, Marko Simunovic

    Published 2018-01-01
    “…Median wait times from referral to colonoscopy met the recommendations set out by the Canadian Association of Gastroenterology and Cancer Care Ontario for all indications: chronic abdominal pain: 43 days; new onset change in bowel habits: 36 days; bright red rectal bleeding: 42 days; documented iron-deficiency anemia: 43 days; fecal occult blood test positive: 38 days; cancer likely based on imaging or physical exam: 23 days; chronic diarrhea and chronic constipation: 42 days; and screening colonoscopies: 55 days. …”
    Get full text
    Article